This receptor-based characterization has been further refined by means of mRNA expression analyses, with receptor-positive cancers comprising mainly the luminal A, luminal B and HER2-enriched subcategories [37], and most TNBC classified as basal-like [38]. This evidence concerns the gene ERBB2 and cancer.